This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $10 million IDC provides data licensing, data acquisition and management, and drug use surveillance services to support the FDA's post-marketing surveillance of non-medical use of pharmaceuticals and use of illicit drug substances. Two task orders have been issued under this IDC. The...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Iqvia Government Solutions Inc., a prominent healthcare data and analytics provider. The contract, valued at up to $3,169,963.15, provides the FDA with access to over-the-counter (OTC) drug utilization data to strengthen the agency's drug monitoring and safety surveillance programs. Through a series of firm fixed price delivery...
The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded an Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide synthesis and distribution services for drugs of abuse and related compounds. The contract has a ceiling value of $14,004,330 and a period of performance from June 9, 2022 to June 8, 2027. This contract supports NIDA's mission of conducting...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Emmes Company LLC, a for-profit limited liability company, to serve as the NIDA Data, Statistics, and Clinical Trial Support Center. Under this single-award IDIQ contract valued up to $31.2 million over a five-year period from September 2022 to September 2027, The...
The National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract titled "Toxicological Evaluations of Potential Medications" to Sri International, a non-profit research and development institute. The IDIQ has a ceiling value of $9,750,000 and a 5-year ordering period from September 12, 2023 through September 11, 2028. Under this IDIQ, Sri International will conduct...
The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Iqvia Government Solutions Inc. to provide hospital drug utilization data and regulatory drug utilization services. The base period of performance is from March 2020 through March 2025 with a potential value of $9 million. Under the first delivery order valued at $3.667 million, Iqvia will deliver hospital drug data from Silver Spring, Maryland through April 2025. The...
The National Institute on Drug Abuse, a division of the Department of Health and Human Services, awarded an Indefinite Delivery Contract to The Bizzell Group LLC to provide logistics, communications, and clinical study auxiliary support services to the Division of Therapeutics and Medical Consequences. The contract has a potential value of $1,000,000 and a period of performance from May 1, 2021 to April 30, 2026. Under the contract, The Bizzell Group LLC has received various delivery orders...
The federal contract IDV award, valued up to $10 million, was issued by the U.S. Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health), a U.S. local/state government entity and healthcare provider. The contract provides data resources to support the FDA's post-marketing surveillance of nonmedical use of pharmaceuticals and illicit drug use. Under this IDV, Denver Health has been awarded multiple firm fixed-price delivery orders. These include a $205,010...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Information Management Services, Inc. (IMS). The $75 million ceiling IDC runs through November 2030 and tasks IMS with operating the NIDDK Central Data Repository and strengthening NIDDK's data sharing capabilities. IMS, a for-profit Subchapter S...
This indefinite delivery contract (IDC) was awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA), a civilian agency within the U.S. Department of Health and Human Services, to Education Development Center, Inc. (EDC), a nonprofit organization. The contract, valued at up to $1,000, has a performance period through July 2027 and does not involve any set-asides. The purpose of this IDC is to provide SAMHSA with training, technical assistance, and resources to support...